Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

GSK679586

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
The overall efficacy and safety of anti-interleukin (IL)-13 therapies remain to be fully characterized. We conducted a meta… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2014
Highly Cited
2014
BACKGROUND Approximately 5% to 10% of asthmatic patients achieve incomplete symptom control on current therapies. The association… Expand
  • figure 1
  • table II
  • table I
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2013
Highly Cited
2013
AIMS IL-13 is implicated as an important mediator of the pathology of asthma. This first clinical study with GSK679586, a novel… Expand
  • figure 1
  • table 1
  • table 1
  • table 2
  • table 3
Is this relevant?